Leazer manager of the Madison angel group Wisconsin Investment Partners said he sees the growth of angel investing following several other factors as well: The rise of the stock market and overall investor confidence. Positive ripples from the sale of Madison-based Bone Care to Genzyme last year for $600 million. Bone Care went public in 1996. Established angel netw